Alectinib for untreated ALK-positive advanced non-small-cell lung cancer: Technology appraisal guidance [TA536] – NICE

Evidence-based recommendations on alectinib (Alecensa) for untreated anaplastic lymphoma kinase (ALK)-positive advanced non-small-cell lung cancer in adults. Alectinib is recommended, within its marketing authorisation, as an option for untreated anaplastic lymphoma kinase (ALK)-positive advanced non-small-cell lung cancer (NSCLC) in adults.

Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer: Technology appraisal guidance [TA531] – NICE

Evidence-based recommendations on pembrolizumab (Keytruda) for untreated PD-L1-positive metastatic non-small-cell lung cancer in adults. This guidance replaces NICE technology appraisal guidance 447.

Lung cancer clinical outcomes publication 2017 (for surgical operations performed in 2015) – Royal College of Physicians and The Society for Cardiothoracic Surgery in Great Britain and Ireland

The clinical outcomes publication is an NHS England initiative, commissioned by the Healthcare Quality Improvement Partnership (HQIP), to publish quality measures at unit level and the level of individual consultant doctor using national clinical audit and administrative data. The following

Literature review: the economic costs of lung disease and the cost effectiveness of policy and service interventions – British Thoracic Society

This report describes the conduct and results of a literature review of the available evidence on the economic costs of lung disease and the cost effectiveness of policy and service interventions. It finds: A substantial evidence base exists on non-pharmaceutical policy-related interventions for

A Lung Health Service: Doncaster Pharmacy Direct Referral For Chest X-Ray: A project summary – Cancer Research UK

The Accelerate, Coordinate, Evaluate (ACE) Programme is an early diagnosis of cancer initiative focused on testing innovations that either identify individuals at high risk of cancer earlier or streamline diagnostic pathways. It was set-up to accelerate the pace of change in this area